Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

Now deemed offensive?
'Nice to be together'
Highest tax burden
Fire a homicide?
Escobar's hippos
James Beard Awards
Pink diamond auction
Shooter hoax calls
Denies breaking law
Lana Del Rey engaged?
San Jose hit-and-run
Gas price gouging law
Ky. helicopter crash
Touchdown in Tanzania
Trash strike ends
'I chose to survive'
Smashing Pumpkins tour
New Penn State coach
Essence Festival 2023
'It's the best gift'
Dior Fall 2023
'Thunderbolts' scribe
Myanmar condemned
Biden eco regulation
Jury takes a break
Baldwin 'Rust' case
Restricted on Twitter
Marburg cases reported
Ship fire kills 12
To lay off 6% of staff
Unlimited life span
NC no-permit gun bill
Emergency landing
Chicago mayoral debate
Rangers sign Chytil
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
1,080 results
Yahoo1mon
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
It's unclear how Catalent will proceed or whether it's receptive to a takeover offer, Bloomberg reported citing people familiar with the matter. Danaher and Catalent deal could be one of the ...
Nasdaq1mon
Danaher interested in buying life sciences firm Catalent- Bloomberg News
Danaher's approach to Catalent values it at a significant premium, the report said, adding that unclear how Catalent will proceed or whether it is receptive to a takeover offer. A deal is not ...
CNBC29d
We're adding to our position in this robust medical technology player
Notably, Bloomberg earlier this month reported that Danaher was interested in acquiring life sciences firm Catalent (CTLT). Although the initial reaction to this news was mixed, the market should ...
Yahoo Finanzas1mon
Danaher Takes Interest in Life Sciences Firm Catalent
(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
TheStreet.com2d
Danaher (DHR) Stock Soaring on Pall Corp. Acquisition, Split Announcements
Danaher (DHR) stock is rising after the company announced it will acquire Pall Corp. (PLL) and split itself into two companies. Danaher (DHR) stock is rising after the company announced it will ...
TheStreet.com13d
Pall Corp. (PLL) Stock Jumping on $13.8 Billion Danaher Takeover
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Fox News2d
New Jersey AG announces state takeover of Paterson Police Department
Platkin said the takeover amounted to a "pledge" to residents and officers that the state is committed to safety in the city. Isa Abbassi, a 25-year veteran of the New York Police Department ...
Barron's2d
Blackbaud Rejects $71-a-Share Takeover Offer From Clearlake as Too Low
Blackbaud shares are trading sharply higher after the company received, and turned down, a $71-a-share takeover bid from the private investment firm Clearlake Capital Group. Clearlake disclosed ...
CNBC21d
Danaher's stock drop looks like a buying opportunity after it reported a solid quarter
Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.
Benzinga.com2d
Danaher Schedules First Quarter 2023 Earnings Conference Call
WASHINGTON, March 27, 2023 /PRNewswire/ -- Danaher Corporation DHR announced that it will webcast its quarterly earnings conference call for the first quarter 2023 on Tuesday, April 25 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback